People taking the most common GLP-1 drugs lost an average of 33 pounds while on treatment, but gained back about 22 pounds within a year of stopping, study co-author Sam West told The Washington Post
Moreover, AI technology can be used to accelerate the design and screening of novel GLP-1R agonists to promote personalized therapy
Telomerase, also known as terminal transferase, is a ribonucleoprotein adding a species-dependent telomere repeat sequence to the 3end of telomeres
The company has become the first Indian pharmaceutical firm to receive approval from the Drugs Controller General of India (DCGI) for a generic version of semaglutide
Whats more, curcumin could ameliorate renal lesions caused by autophagic dysfunction of podocytes in high glucose levels through the PI3K/Akt/mTOR pathway
Vyrobeno ve Francii, balen vysta na jednu porci